These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9059668)

  • 21. Single-strand conformation polymorphism analysis of point mutation in a tyrosinase-negative oculocutaneous albinism.
    Park KC; Kim KH; Lee YS; Kwon BS
    J Inherit Metab Dis; 1994; 17(1):123-6. PubMed ID: 8051921
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper.
    Matsunaga J; Dakeishi-Hara M; Miyamura Y; Nakamura E; Tanita M; Satomura K; Tomita Y
    Dermatology; 1998; 196(2):189-93. PubMed ID: 9568405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H; Ishiko A; Kikuchi A; Akiyama M; Suzumori K; Nishikawa T
    Lancet; 1992 Sep; 340(8821):739-40. PubMed ID: 1355848
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
    Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
    Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
    Giebel LB; Spritz RA
    Pigment Cell Res; 1992; Suppl 2():101-6. PubMed ID: 1409411
    [No Abstract]   [Full Text] [Related]  

  • 31. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS; King RA
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of oculocutaneous albinism with molecular analysis.
    Summers CG; Oetting WS; King RA
    Am J Ophthalmol; 1996 Jun; 121(6):724-6. PubMed ID: 8644824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
    Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
    Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of TYR mutations in patients with oculocutaneous albinism.
    Sun W; Shen Y; Shan S; Han L; Li Y; Zhou Z; Zhong Z; Chen J
    Mol Med Rep; 2018 Jun; 17(6):8409-8413. PubMed ID: 29658579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mouse model of tyrosinase positive type oculocutaneous albinism (chinchilla mouse, Cch/Cch) : tyrosinase activity and ultrastructure of hair bulb melanocyte (author's transl)].
    Hori Y; Shichiro M; Mizoguchi M
    Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):987-94. PubMed ID: 6780712
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidermal melanocytes in normal and tyrosinase-negative oculocutaneous albinism fetuses.
    Kikuchi A; Shimizu H; Nishikawa T
    Arch Dermatol Res; 1995; 287(6):529-33. PubMed ID: 7487137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Might the refractive state in oculocutaneous albino patients be a clue for distinguishing between tyrosinase-positive and tyrosinase-negative forms of oculocutaneous albinism?
    Käsmann B; Ruprecht KW
    Ger J Ophthalmol; 1996 Nov; 5(6):422-7. PubMed ID: 9479530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.